Continuous Manufacturing Centers Of Excellence Measure Resurfaces In US House
Executive Summary
Stand-alone bill headed for Senate, where it fared poorly in coronavirus response legislative packages.
You may also be interested in...
Advanced Manufacturing Centers Of Excellence Measure Finally Clears US Congress
Nearly four years after introduction and a half-dozen legislative attempts, proposal to establish academic centers of excellence – hoped to help usher in a renaissance in US pharmaceutical manufacturing – secures passage in omnibus spending bill. New law also supports emerging technologies, building on the FDA’s Critical Path Initiative.
Continuous Pharmaceutical Manufacturing Bill Hitches A Ride With US FDA User Fee Legislation
US legislation could advance new manufacturing platforms for drugs and biologics with academic R&D and workforce development and in turn spur domestic growth.
Continuous Manufacturing Back In Second Act
House tries again to promote advanced technology for the return of pharmaceutical manufacturing to the US in post-COVID-19 era.